Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide: a pathogenetic factor in autoimmunity.

H Kolb1, V Kolb-Bachofen

  • 1Diabetes Research Institute, University of Düsseldorf, FRG.

Immunology Today
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease.

The journal of prevention of Alzheimer's disease·2024
Same author

JCV seroconversion rate during the SARS COVID-19 pandemic.

Multiple sclerosis and related disorders·2022
Same author

Reinforcing the evidence of oligoclonal bands as a prognostic factor in patients with Multiple sclerosis.

Multiple sclerosis and related disorders·2021
Same author

Simultaneous measurement of all thermoelectric properties of bulk materials in the temperature range 300-600 K.

The Review of scientific instruments·2015
Same author

Type I diabetes - an autoimmune disease?

Immunology today·2014
Same author

New concepts in immunotherapy.

Immunology today·2014
Same journal

Foreword.

Immunology today·2020
Same journal

The origin and significance of anti-DNA antibodies.

Immunology today·2014
Same journal

Mutations of class II MHC molecules.

Immunology today·2014
Same journal

Antigen processing at the molecular level.

Immunology today·2014
Same journal

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Immunology today·2014
Same journal

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014
See all related articles

Nitric oxide (NO), a key mediator in many bodily functions, is increasingly recognized for its role in inflammatory and autoimmune diseases. Targeting NO production offers a promising new therapeutic strategy for these conditions.

Area of Science:

  • Biochemistry
  • Immunology
  • Physiology

Background:

  • Nitric oxide (NO) is a recently identified multifunctional mediator produced by and acting on most body cells.
  • NO serves critical roles as an endothelium-derived relaxing factor, neurotransmitter, and immune defense molecule.
  • Emerging evidence implicates NO in the tissue destruction associated with inflammatory and autoimmune conditions.

Purpose of the Study:

  • To explore the multifaceted roles of nitric oxide (NO) in biological systems.
  • To investigate the involvement of NO in inflammatory and autoimmune processes.
  • To evaluate the therapeutic potential of modulating NO synthesis and action in treating inflammatory and autoimmune diseases.

Main Methods:

  • Literature review of NO's functions and involvement in disease.

Related Experiment Videos

  • Analysis of existing research on NO synthesis and its effects.
  • Exploration of therapeutic strategies targeting NO pathways.

    • Main Results:

    • NO is a versatile signaling molecule with diverse physiological functions.
    • NO plays a significant role in the pathogenesis of inflammatory and autoimmune diseases.
    • Modulation of NO pathways presents a novel therapeutic avenue.

    Conclusions:

    • Nitric oxide is a critical mediator implicated in tissue damage during inflammation and autoimmunity.
    • Targeting NO synthesis and action offers a promising therapeutic approach for managing inflammatory and autoimmune disorders.